Steven Hyman

Steven Hyman

Directeur/Membre du Conseil chez CYCLERION THERAPEUTICS, INC.

Fortune : 63 000 $ au 31/05/2026

73 ans
Commercial Services
Health Technology
Consumer Services

Profil

Steven E.
Hyman
is the founder of Emugen Therapeutics LLC.
Current positions include Chairman at The Dana Foundation since 2018, Director at Janssen Pharmaceuticals, Inc., Director-Stanley Center Psychiatric Research at Massachusetts Institute of Technology since 2012, Director at Charles H.
Revson Foundation, Inc., Director-Stanley Center for Psychiatric Research at The Broad Institute, Inc. since 2012, Independent Director at Voyager Therapeutics, Inc. since 2015, Independent Director at Q-State Biosciences, Inc. since 2020, Independent Director at Cyclerion Therapeutics, Inc. since 2022, Member of the National Academy of Medicine (United States) since 2000, President of the American College of Neuropsychopharmacology since 2018, and Member of the National Academy of Sciences.
Former positions include Director at the National Institute of Mental Health from 1996 to 2001, Professor at Harvard University from 2001 to 2011, Member-Governing Board at The National Research Council from 2016 to 2018, President of the Society For Neuroscience, Strategic Advisor at Access BridgeGap Ventures, and President of the International Neuroethics Society from 2008 to 2013.
Education includes graduate degree from the University of Cambridge in 1976, doctorate from Harvard Medical School, and undergraduate degree from Yale College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/03/2026 20 000 ( 0,46% ) 63 000 $ 31/05/2026
09/06/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Steven Hyman

SociétésPosteDébut
VOYAGER THERAPEUTICS, INC. Directeur/Membre du Conseil 17/09/2015
CYCLERION THERAPEUTICS, INC. Directeur/Membre du Conseil 25/07/2022
Corporate Officer/Principal 01/01/2012
Corporate Officer/Principal 01/01/2000
President 01/01/2018
Directeur/Membre du Conseil -
Président 01/12/2018
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/01/2014
░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Anciens postes connus de Steven Hyman

SociétésPosteFin
░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Steven Hyman

Formation de Steven Hyman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Health Technology

Consumer Services

Consumer Services

Finance

Commercial Services

Commercial Services

Commercial Services

Government

Commercial Services

Commercial Services

Health Technology

Consumer Services

Miscellaneous

Finance

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Emugen Therapeutics LLC

  1. Bourse
  2. Insiders
  3. Steven Hyman
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT